A Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy Participants
Clinical trial NCT02074800 · COMPLETED
Trial details
- NCT number
- NCT02074800
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-06-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.